SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DEVICE: SurgiMend® Acellular Dermal Matrix|DEVICE: Strattice™ Acellular Dermal Matrix
Sponsor: Aarhus University Hospital